Extended-release pramipexole in early Parkinson disease: A 33-week randomized controlled trial

To assess the clinical efficacy of a novel once-daily extended-release (ER) formulation of the dopamine agonist pramipexole as monotherapy in patients with early Parkinson disease (PD) and establish its noninferiority vs standard immediate-release (IR) pramipexole. This was a multicenter, double-bli...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurology 2011-08, Vol.77 (8), p.759-766
Hauptverfasser:	POEWE, W, RASCOL, O, BARONE, P, HAUSER, R. A, MIZUNO, Y, HAAKSMA, M, SALIN, L, JUHEL, N, SCHAPIRA, A. H. V
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Analysis of Variance Antiparkinson Agents - therapeutic use Benzothiazoles - therapeutic use Biological and medical sciences Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Double-Blind Method Drug Administration Schedule Drug Delivery Systems Female Follow-Up Studies Humans Male Medical sciences Middle Aged Neurology Parkinson Disease - drug therapy Severity of Illness Index Surveys and Questionnaires Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!